Advertisement

#Rituxan

A peripheral blood smear showing several hairy leukemia cells

For Hairy Cell Leukemia, Drug Combination Leads to Long-Lasting Remissions

A combination of two targeted therapies led to long-lasting remission in a small study of patients with hairy cell leukemia.

Rituxan

Targeted Treatment for Leukemia

Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.

Jennifer Woyach, MD

Imbruvica Bests Chemotherapy for Older People With Leukemia

Imbruvica-based treatment may also work better than intensive chemotherapy for younger patients.

How New Drugs Become Available to More Patients

Filling in the unknowns on the balance between risk and benefit

Red and white blood cells

Targeted Therapies Improve Outcomes for People With Chronic Lymphocytic Leukemia

Venclexta combination therapy clears leukemia in blood and bone marrow, recent studies show.

Red and white blood cells

Maintenance Therapy Reduces Progression in People With Leukemia

Revlimid improves outcomes for chronic lymphocytic leukemia patients, but better drugs are now available.

Advertisement